This follows limited but successful testing in Brazil, where patients who underwent surgery with TranS1 catheters had no postoperative back pain and now lead active lives.
The current recommendation of 3 months of warfarin treatment after bioprosthetic AVR surgery is primarily based on results from 1 retrospective study with a limited number of events.